Effectiveness of Cardiopulmonary Exercises for Children With Pectus Excavatum

February 25, 2026 updated by: Ayse Naz Kalem, Ankara Etlik City Hospital

The Effectiveness of Cardiopulmonary Exercise in Children With Pectus Excavatum: A Single-Blind, Randomised Controlled Trial

The aim of this study is to investigate the effects of cardiopulmonary rehabilitation on respiratory function, exercise tolerance and posture in patients with pectus excavatum.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Ayse Naz Kalem Ozgen, Specialist
  • Phone Number: +90 0312 797 00 00
  • Email: kalemnaz@gmail.com

Study Locations

    • Yenimahalle
      • Ankara, Yenimahalle, Turkey (Türkiye), 06010
        • Recruiting
        • Ankara Etlik City Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Children aged 5-18 years with pectus excavatum deformity
  2. Children undergoing conservative treatment (vacuum orthosis, exercise)
  3. Patients whose families have signed a consent form agreeing to participate in the study

Exclusion Criteria:

  1. Known cardiac disease
  2. Presence of an additional syndrome (Marfan syndrome, etc.)
  3. Cobb angle ≥10°
  4. Refusal to participate in the study
  5. Presence of mixed deformity (pectus arcuatum)
  6. Those with an indication for surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: cardiopulmonary exercises group at hospital
The working group will be provided with a personalised exercise plan by a physiotherapist specialising in that field at the cardiopulmonary rehabilitation unit, to be carried out twice a week for five weeks. Patients will work on a bicycle ergometer. In addition, the same physiotherapist will demonstrate breathing and posture exercises for patients to perform at home.
Patients will exercise using a bicycle ergometer. In addition, the same physiotherapist will demonstrate breathing and posture exercises for them to perform at home.
Active Comparator: pulmonary exercises group at home
The physiotherapist will only demonstrate the breathing and posture exercises that patients in the control group will perform at home.
The physiotherapist will demonstrate the breathing and posture exercises to be performed at home.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Maximal inspiration and expiration pressure
Time Frame: first day of exercises program and 5th week of exercises program
first day of exercises program and 5th week of exercises program

Secondary Outcome Measures

Outcome Measure
Time Frame
6 minute walking test
Time Frame: first day of exercises program and 5th week of exercises program
first day of exercises program and 5th week of exercises program
New York Posture Scale
Time Frame: first day of exercises program and 5th week of exercises program
first day of exercises program and 5th week of exercises program
Measurement of chest expansion in centimetres using a tape measure
Time Frame: first day of exercises program and 5th week of exercises program
first day of exercises program and 5th week of exercises program
Assessment of symptoms (exercise intolerance, psychological impact, resting dyspnoea, chest pain, spinal pain, gastrointestinal symptoms, palpitations, dyspnoea) using a visual analogue scale
Time Frame: first day of exercises program and 5th week of exercises program
first day of exercises program and 5th week of exercises program
Cobb angle analysis using the Diers Formatrix 4D device (Wiesbaden, Germany)
Time Frame: first day of exercises program and 5th week of exercises program
first day of exercises program and 5th week of exercises program
Thoracic kyphosis angle
Time Frame: first day of exercises program and 5th week of exercises program
first day of exercises program and 5th week of exercises program
body lenght
Time Frame: first day of exercises program and 5th week of exercises program
first day of exercises program and 5th week of exercises program
Saggital balance angle using the Diers Formatrix 4D device (Wiesbaden, Germany)
Time Frame: first day of exercises program and 5th week of exercises program
first day of exercises program and 5th week of exercises program
Coronal balance angle using the Diers Formatrix 4D device (Wiesbaden, Germany)
Time Frame: first day of exercises program and 5th week of exercises program
first day of exercises program and 5th week of exercises program
pelvic obliquity angle using the Diers Formatrix 4D device (Wiesbaden, Germany)
Time Frame: first day of exercises program and 5th week of exercises program
first day of exercises program and 5th week of exercises program

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 9, 2025

Primary Completion (Estimated)

May 9, 2026

Study Completion (Estimated)

May 9, 2026

Study Registration Dates

First Submitted

November 13, 2025

First Submitted That Met QC Criteria

December 18, 2025

First Posted (Actual)

December 24, 2025

Study Record Updates

Last Update Posted (Actual)

February 27, 2026

Last Update Submitted That Met QC Criteria

February 25, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pectus Excavatum Deformity

Clinical Trials on Cardiopulmonary exercises at hospital

Subscribe